ArticleCurrent neuropharmacology2022

Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention.

Konrad Rejdak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.